Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Royalty Pharma plc - SIC # 6794 - PATENT OWNERS AND LESSORS
Ticker
Exchange
SIC #
Website
Latest Ticker
RPRX
Nasdaq
6794
www.royaltypharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Royalty Pharma plc
Royalty Pharma to Present at Upcoming Investor Conferences
- Nov 27th, 2024 9:15 pm
Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood?
- Nov 27th, 2024 4:11 pm
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
- Nov 14th, 2024 9:30 pm
Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues
- Nov 13th, 2024 11:59 am
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
- Nov 7th, 2024 12:10 pm
Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions
- Nov 7th, 2024 7:10 am
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight
- Nov 7th, 2024 5:08 am
Royalty Pharma Reports Third Quarter 2024 Results
- Nov 6th, 2024 12:15 pm
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo
- Nov 4th, 2024 9:15 pm
Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™
- Nov 4th, 2024 9:01 pm
Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks
- Nov 3rd, 2024 11:11 am
Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024
- Oct 16th, 2024 8:15 pm
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21
- Oct 14th, 2024 10:33 am
Royalty Pharma Declares Fourth Quarter 2024 Dividend
- Oct 11th, 2024 12:15 pm
Royalty Pharma PLC (RPRX) Q2 2024 Earnings Call Highlights: Surpassing Growth Expectations and ...
- Oct 9th, 2024 9:31 pm
Royalty Pharma plc (RPRX): Among The Stocks With Biggest Upside Potential According to Hedge Funds
- Oct 9th, 2024 7:50 pm
Royalty Pharma plc's (NASDAQ:RPRX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
- Sep 6th, 2024 1:34 pm
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
- Sep 3rd, 2024 9:14 pm
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
- Sep 3rd, 2024 9:06 pm
Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference
- Aug 28th, 2024 8:15 pm
Scroll